$3.62
+5.09%
2026-09-04 09:55:39 EDT+$0.18
헬스케어
생명공학
NASDAQ
활발히 거래 중
Recursion Pharmaceuticals, Inc.는 현재 임상 개발 단계에 있는 생명공학 기업으로서 활동하고 있습니다. 회사의 미션은 생물학적 과정을 해독함으로써 약물 발견을 혁신하는 것이며, 생물학, ...
Recursion Pharmaceuticals, Inc.는 현재 임상 개발 단계에 있는 생명공학 기업으로서 활동하고 있습니다. 회사의 미션은 생물학적 과정을 해독함으로써 약물 발견을 혁신하는 것이며, 생물학, ...
| 날짜 | 임원 | 직책 | 증권 | 구분 | 주식 수 | 가격 |
|---|---|---|---|---|---|---|
| Sep 1, 2026 | Borgeson Blake | director | Class A Common Stock | D | 30,000 | $3.34 |
| Aug 17, 2026 | Khan Najat | director, officer: CEO and President | Class A Common Stock | D | 80,498 | $3.16 |
| Aug 17, 2026 | Hallett David | officer: Chief Scientific Officer | Class A Common Stock | D | 26,657 | $3.16 |
| Aug 17, 2026 | Taylor Ben R | officer: Chief Financial Officer | Class A Common Stock | D | 25,018 | $3.16 |
| Aug 4, 2026 | Borgeson Blake | director | Class A Common Stock | D | 30,000 | $3.25 |
매수/매도 주식 수와 종가 추세(공통 일간 가격 소스)
X축: 주식 수, 총 주식 수 내림차순
X축: 건수, A+D 건수 내림차순
| 날짜 | 임원 | 직책 | 증권 | 구분 | 주식 수 | 가격 | 금액 |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | Borgeson Blake | director | Class A Common Stock | D | 30,000 | $3.34 | $100,200.00 |
| Aug 17, 2026 | Khan Najat | director, officer: CEO and President | Class A Common Stock | D | 80,498 | $3.16 | $254,373.68 |
| Aug 17, 2026 | Hallett David | officer: Chief Scientific Officer | Class A Common Stock | D | 26,657 | $3.16 | $84,236.12 |
| Aug 17, 2026 | Taylor Ben R | officer: Chief Financial Officer | Class A Common Stock | D | 25,018 | $3.16 | $79,056.88 |
| Aug 4, 2026 | Borgeson Blake | director | Class A Common Stock | D | 30,000 | $3.25 | $97,500.00 |
| Jul 7, 2026 | Borgeson Blake | director | Class A Common Stock | D | 40,000 | $3.96 | $158,500.00 |
| Jul 1, 2026 | Dar Zavain | director | Class A Common Stock | A | 5,109 | — | — |
| Jul 1, 2026 | Li Dean Y | director | Class A Common Stock | A | 3,747 | — | — |
| Jun 18, 2026 | Bumpus Namandje | director | Class A Common Stock | D | 3,963 | $3.18 | $12,602.34 |
| Jun 17, 2026 | Borgeson Blake | director | Class A Common Stock | A | 88,424 | — | — |